204 results  1 of 11 

1 Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study
Ji Min Han, Jung Hwan Cho, Hye In Kim, Sunghwan Suh, Yu-Ji Lee, Jung Won Lee, Kwang Min Kim, Ji Cheol Bae
Endocrinol Metab.2023;38(4):418-425.   Published online 2023 July 12     DOI: http://dx.doi.org/10.3803/EnM.2023.1729
      
2 Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
Yujin Jin, Kyung-Sun Heo
Korean J Physiol Pharmacol.2023;27(4):299-310.   Published online 2023 July 1     DOI: http://dx.doi.org/10.4196/kjpp.2023.27.4.299
      
3 Associations between Vitamin D and Indicators of Common Chronic Diseases in Korean Adults
Hye-Ryung Yoon, Hyuksin Kwak, Eun-Hee Nah, Chi-Hyun Cho
Lab Med Online.2023;13(3):223-229.   Published online 2023 July 1     DOI: http://dx.doi.org/10.47429/lmo.2023.13.3.223
      
4 Exercise Capacity and Pulmonary Capacitance Are Attenuated in Patients with Nonalcoholic Steatohepatitis
Joshua Donkor, Alex R. Carlson, Briana L. Ziegler, Jessica I. Johnston, Jinkyung Cho, Bruce D. Johnson, Chul-Ho Kim
Korean J Sports Med.2023;41(2):107-110.   Published online 2023 June 1     DOI: http://dx.doi.org/10.5763/kjsm.2023.41.2.107
      
5 위암 생존자에서 대사증후군과 지방간의 위험도: 성향점수매칭 분석
Sang Jo Han, Su Jung Baik, Young Hoon Yoon, Jie Hyun Kim, Hye Sun Lee, Soyoung Jeon, Hyojin Park
Korean J Gastroenterol.2023;81(4):154-162.   Published online 2023 April 25     DOI: http://dx.doi.org/10.4166/kjg.2022.113
      
6 Beneficial Effects of a Curcumin Derivative and Transforming Growth Factor-β Receptor I Inhibitor Combination on Nonalcoholic Steatohepatitis
Kyung Bong Ha, Eun Soo Lee, Na Won Park, Su Ho Jo, Soyeon Shim, Dae-Kee Kim, Chan Mug Ahn, Choon Hee Chung
Diabetes Metab J.2023;47(4):500-513.   Published online 2023 April 25     DOI: http://dx.doi.org/10.4093/dmj.2022.0110
      
7 Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
Diabetes Metab J.2023;47(3):347-355.   Published online 2023 March 29     DOI: http://dx.doi.org/10.4093/dmj.2022.0444
      
8 Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes
Seung Min Chung, Min Kyu Kang, Jun Sung Moon, Jung Gil Park
Endocrinol Metab.2023;38(2):277-281.   Published online 2023 March 13     DOI: http://dx.doi.org/10.3803/EnM.2022.1635
      
9 Non-alcoholic fatty liver disease-related hepatocellular carcinoma
Darine Daher, Karim Seif El Dahan, Amit G. Singal
J Liver Cancer.2023;23(1):127-142.   Published online 2023 February 9     DOI: http://dx.doi.org/10.17998/jlc.2022.12.30
      
10 Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
Hwi Seung Kim, Jiwoo Lee, Eun Hee Kim, Min Jung Lee, In Young Bae, Woo Je Lee, Joong-Yeol Park, Hong-Kyu Kim, Chang Hee Jung
Diabetes Metab J.2023;47(1):104-117.   Published online 2023 January 26     DOI: http://dx.doi.org/10.4093/dmj.2022.0081
      
11 Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus
Yongin Cho, Hye-Sun Park, Byung Wook Huh, Yong-ho Lee, Seong Ha Seo, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim
Diabetes Metab J.2023;47(2):232-241.   Published online 2023 January 19     DOI: http://dx.doi.org/10.4093/dmj.2021.0355
      
12 Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
Diabetes Metab J.2023;47(2):220-231.   Published online 2023 January 12     DOI: http://dx.doi.org/10.4093/dmj.2021.0327
      
13 Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease
Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee
J Korean Med Sci.2022;37(49):e339.  Published online 2022 November 16     DOI: http://dx.doi.org/10.3346/jkms.2022.37.e339
      
14 The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
Dae-Jeong Koo, Won-Young Lee
Cardiovasc Prev Pharmacother.2022;4(4):132-141.   Published online 2022 October 20     DOI: http://dx.doi.org/10.36011/cpp.2022.4.e17
      
15 Pharmacological Treatment of Nonalcoholic Fatty Liver Disease: Antidiabetic Agents
Kyung-Soo Kim
J Korean Diabetes.2022;23(2):83-88.   Published online 2022 June 30     DOI: http://dx.doi.org/10.4093/jkd.2022.23.2.83
      
16 Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
Songling Jiang, Md Jamal Uddin, Xiaoying Yu, Lingjuan Piao, Debra Dorotea, Goo Taeg Oh, Hunjoo Ha
Diabetes Metab J.2022;46(6):829-842.   Published online 2022 June 24     DOI: http://dx.doi.org/10.4093/dmj.2021.0274
      
17 The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider
Endocrinol Metab.2022;37(3):455-465.   Published online 2022 June 21     DOI: http://dx.doi.org/10.3803/EnM.2022.1434
      
18 Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective
Ki Hyun Kim, Yoonhong Kim, Kwang Il Seo, Kyung Won Seo
Ann Surg Treat Res.2022;102(6):353-359.   Published online 2022 June 7     DOI: http://dx.doi.org/10.4174/astr.2022.102.6.353
      
19 Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
Xin-Lei Zhang, Ting-Yao Wang, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng
Diabetes Metab J.2022;46(3):391-401.   Published online 2022 May 25     DOI: http://dx.doi.org/10.4093/dmj.2022.0048
      
20 Mulberry (Morus alba L.) ethanol extract attenuates lipid metabolic disturbance and adipokine imbalance in high-fat fed rats
Da-jung Noh, Gun-Ae Yoon
Nutr Res Pract.2022;16(6):716-728.   Published online 2022 May 9     DOI: http://dx.doi.org/10.4162/nrp.2022.16.6.716
      

 1 of 11